Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
Overcoming multidrug resistance has always been a major challenge in cancer treatment. Recent evidence suggested epithelial-mesenchymal transition plays a role in MDR, but the mechanism behind this link remains unclear. We found that the expression of multiple ABC transporters was elevated in concor...
Principais autores: | Lim, Maegan Miang Kee, Wee, Jonathan Wei Kiat, Soong, Jen Chi, Chua, Damien, Tan, Wei Ren, Lizwan, Marco, Li, Yinliang, Teo, Ziqiang, Goh, Wilson Wen Bin, Zhu, Pengcheng, Tan, Nguan Soon |
---|---|
Outros Autores: | School of Biological Sciences |
Formato: | Journal Article |
Idioma: | English |
Publicado em: |
2019
|
Assuntos: | |
Acesso em linha: | https://hdl.handle.net/10356/103567 http://hdl.handle.net/10220/47340 |
Registros relacionados
-
The role of angiopoietin-like 4 (ANGPTL4) in chemoresistance and autophangy during epithelial-mesenchymal transition (EMT)
por: Lim, Maegan Miang Kee
Publicado em: (2019) -
Emerging roles of angiopoietin-like 4 in human cancer
por: Tan, Ming Jie, et al.
Publicado em: (2012) -
Angiopoietin-like 4 Mediates Colonic Inflammation by Regulating Chemokine Transcript Stability via Tristetraprolin
por: Phua, Terri, et al.
Publicado em: (2017) -
YWHAG deficiency disrupts the EMT-associated network to induce oxidative cell death and prevent metastasis
por: Lee, Jeannie Xue Ting, et al.
Publicado em: (2024) -
Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial–mesenchymal transition by inducing 14-3-3γ expression
por: Teo, Ziqiang, et al.
Publicado em: (2018)